We often see regulatory actions against various financial entities after the regulator has “inspected their books”. Recent regulatory action includes restrictions on accepting deposits, opening new accounts through online banking channels, issuing co-branded cards, launching new mobile products, and managing debt public issues. These actions reflect the regulators’ commitment to maintaining financial stability, fair markets, and ensuring compliance with regulations. However, investors view such action with shock and awe, as they impact them directly.
Another sector that periodically sees inspections — and regulatory action — is pharmaceutical firms exporting to the US. Here, inspections are conducted by
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper